Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Cheng Hsieh

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
International Journal of Cardiology|July 8, 2018
Rhythm control better prevents stroke and mortality than rate control strategies in patients with atrial fibrillation - A nationwide cohort studyChi-Jen Weng, Cheng-Hung Li, Ying-Chieh Liao, et al.
Data in Brief|September 22, 2018
Data for rate versus rhythm control strategy on stroke and mortality in patients with atrial fibrillationChi-Jen Weng, Cheng-Hung Li, Ying-Chieh Liao, et al.
Journal of Personalized Medicine|May 28, 2022
Efficacy of Cryoballoon Ablation for Atrial Fibrillation and Recurrence Predictors in an Asian CohortShang-Ju Wu, Cheng-Hung Li, Chi-Jen Weng, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 25, 2023
Ablation of atrial fibrillation and dementia risk reduction during long-term follow-up: a nationwide population-based studyGuan-Yi Li, Yun-Yu Chen, Yenn-Jiang Lin, et al.
Heart Rhythm|March 6, 2012
Ryanodine receptor inhibition potentiates the activity of Na channel blockers against spontaneous calcium elevations and delayed afterdepolarizations in Langendorff-perfused rabbit ventriclesYoung Soo Lee, Mitsunori Maruyama, Po Cheng Chang, et al.
Cardiovascular Diabetology|January 26, 2018
Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational studyCheng-Wei Chan, Chu-Leng Yu, Jiunn-Cherng Lin, et al.
Indian Heart Journal|February 3, 2023
Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA studyBalbir Singh, Yu-Cheng Hsieh, Yen-Bin Liu, et al.
International Journal of Cardiology. Heart & Vasculature|May 17, 2021
Novel model-based point scoring system for predicting stroke risk in atrial fibrillation patients: Results from a nationwide cohort study with validationYun-Yu Chen, Yenn-Jiang Lin, Kuo-Liong Chien, et al.
Journal of Cardiovascular Electrophysiology|July 3, 2021
The mortality analysis of primary prevention patients receiving a cardiac resynchronization defibrillator (CRT-D) or implantable cardioverter-defibrillator (ICD) according to guideline indications in the improve SCA studyChi Keong Ching, Yu-Cheng Hsieh, Yen-Bing Liu, et al.
Journal of Cardiology|June 1, 2021
Mechanism of angiotensin receptor-neprilysin inhibitor in suppression of ventricular arrhythmiaYung-Nan Tsai, Wen-Han Cheng, Yao-Ting Chang, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
International Journal of Cardiology|July 8, 2018
Rhythm control better prevents stroke and mortality than rate control strategies in patients with atrial fibrillation - A nationwide cohort studyChi-Jen Weng, Cheng-Hung Li, Ying-Chieh Liao, et al.
Data in Brief|September 22, 2018
Data for rate versus rhythm control strategy on stroke and mortality in patients with atrial fibrillationChi-Jen Weng, Cheng-Hung Li, Ying-Chieh Liao, et al.
Journal of Personalized Medicine|May 28, 2022
Efficacy of Cryoballoon Ablation for Atrial Fibrillation and Recurrence Predictors in an Asian CohortShang-Ju Wu, Cheng-Hung Li, Chi-Jen Weng, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 25, 2023
Ablation of atrial fibrillation and dementia risk reduction during long-term follow-up: a nationwide population-based studyGuan-Yi Li, Yun-Yu Chen, Yenn-Jiang Lin, et al.
Heart Rhythm|March 6, 2012
Ryanodine receptor inhibition potentiates the activity of Na channel blockers against spontaneous calcium elevations and delayed afterdepolarizations in Langendorff-perfused rabbit ventriclesYoung Soo Lee, Mitsunori Maruyama, Po Cheng Chang, et al.
Cardiovascular Diabetology|January 26, 2018
Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational studyCheng-Wei Chan, Chu-Leng Yu, Jiunn-Cherng Lin, et al.
Indian Heart Journal|February 3, 2023
Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA studyBalbir Singh, Yu-Cheng Hsieh, Yen-Bin Liu, et al.
International Journal of Cardiology. Heart & Vasculature|May 17, 2021
Novel model-based point scoring system for predicting stroke risk in atrial fibrillation patients: Results from a nationwide cohort study with validationYun-Yu Chen, Yenn-Jiang Lin, Kuo-Liong Chien, et al.
Journal of Cardiovascular Electrophysiology|July 3, 2021
The mortality analysis of primary prevention patients receiving a cardiac resynchronization defibrillator (CRT-D) or implantable cardioverter-defibrillator (ICD) according to guideline indications in the improve SCA studyChi Keong Ching, Yu-Cheng Hsieh, Yen-Bing Liu, et al.
Journal of Cardiology|June 1, 2021
Mechanism of angiotensin receptor-neprilysin inhibitor in suppression of ventricular arrhythmiaYung-Nan Tsai, Wen-Han Cheng, Yao-Ting Chang, et al.
Pageof 10